Navigation Links
Tel Aviv University gives preemies a fighting chance
Date:12/4/2007

When a child is born premature and more than one in ten infants in the U.S. is its future is already compromised. One of the common problems associated with premature births is brittle bones, or osteopenia of prematurity (OOP). It can cause bone fractures and rickets in the infant, and osteoporosis later in life.

Tel Aviv University pediatric physicians are championing a training program that aims to make preemies bones stronger. Dr. Dan Nemet and his partner Dr. Alon Eliakim, both associate professors of the Sackler School of Medicine at Tel Aviv University, have developed a proven protocol to prevent OPP.

Says co-researcher Dr. Dan Nemet, About 12% of all births in the United States today are premature. Its unfortunate because its in the last trimester when bones grow the most. More than 30% of preemies born before 30 weeks have some degree of OOP, but wont have any physical symptoms. Its critical to treat it before any symptoms are found.

In the last trimester of pregnancy, mothers transfer large amounts of calcium and phosphorus to the rapidly growing baby. It is also the time when babies exercise acquire muscle and strengthen bones in the womb. And when a child is born early, its physical activity is limited in the incubator. All of these factors contribute to OPP.

The researchers have shown that gentle exercises performed five times a day on the wrist, elbow, shoulder, ankle, knee, and hip joints (approximately 10 minutes for each session), and administered five times per week for four weeks, improved bone strength in preemies as measured using bone ultrasound. Daily interactive periods of holding and stroking the infant also influences bone growth and development, they conclude.

Weve had positive and encouraging results, says Dr. Nemet. The preemies are definitely gaining more bone mass, their bones are growing stronger and subsequently the babies are gaining more weight. We can assume it means that the p
'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...tailing plastic surgery procedures is now availabl...dates can view procedures and print out informatio... (PRWEB) December 2, 2009 -- Recovery..., has always been dedicated to providing resources...es, providing liposuction garments, breast augment...
(Date:12/2/2009)...chieves IBM Ready for LINUX designation and enhanc...mainframe and contemporary systems running Linux. ...ember 2, 2009 -- eCube Systems, a leader in legacy...nounced that it has achieved the IBM Ready for LIN...dleware. This mark certifies NXTera has met compa...
(Date:12/2/2009)...-- A randomized, controlled study comparing standa...eatment called percutaneous disc decompression for...reatments help patients in the short run, only dis...years later. Results of the study, the first of it... of the Radiological Society of North America (RSN...
(Date:12/2/2009)... comparing standard conservative therapy to a mini...decompression for painful herniated disc revealed ...ort run, only disc decompression kept patients pai..., the first of its kind, were presented today at t...orth America (RSNA). , Discs are sponge-like cus...
(Date:12/1/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, The Future of Central Nervous System Dise...etitive Benchmarking, Product Pipeline and Deals A...14/The-Future-of-Central-Nervous-System-Diseases-T...-Benchmarking-Product-Pipeline-and-Deals-Analysis....
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
... Johnson &,Johnson will participate in the Eleven...ence on Tuesday, March 18th at the Loews Miami Bea...resident, Finance and Chief,Financial Officer, wil...,by accessing the Johnson & Johnson website at ht...
... Liu, CEO and Founder of,Ingenious Med and a pract...ntly appointed to serve on the Benchmarks Committe...Liu and the rest of the Benchmarks Committee,will ...arks for hospitalists nationwide in the areas of h...
...athon(R) is pleased to,announce a new Small Child ...der volume instrument with patent-pending NeuralHa...ealth care providers to measure,bladder volume non...ced BladderScan(R) BVI 9400 will make its official...
...rsity of Maryland study of whether people receive ...r race or ethnicity found that when whites and min...ason, they receive the same quality care in that h...ch 11 issue of Health Affairs. The study of 1841 h...
...ral candidate at Georgetown University, has been n...nor Society (Bouchet Society). Crawford is in the...ve Cancer Center, part of the Georgetown Universit...76). The Society aims to recognize outstanding sc...
...or Disease Control has awarded the Indiana Univers...ract with the possibility of nearly $10 million in...ability of local, state and regional entities to s... emergencies. , The funding will allow researcher...
Other Medicine News:Health News:Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3Health News:Minorities, whites get equal care in hospitals 2Health News:Georgetown U student selected for prestigious Bouchet Society 2Health News:Regenstrief Institute tapped by CDC to combat potentially catastrophic disease outbreaks 2
(Date:12/1/2009)... Wash., Dec. 1 SCOLR Pha...ember 20, 2009 it licensed to Chrono Nutraceutical...d sell four extended release dietary supplements u...latform. In addition, SCOLR granted Chrono rights...he United States on a nonexclusive basis. Chrono ...
(Date:12/1/2009)..., Dec. 1 CEL-SCI Corpora...pany and a developer of vaccines and therapeutics ...eases, announced today that it has retained the se...ization (CRO) to run CEL-SCI,s upcoming Phase III ...ancer with the Company,s lead product candidate, M...
(Date:12/1/2009)...LLE, N.C., Dec. 1 nContact Surgica...n of devices for minimally-invasive treatment for ...f a feasibility clinical trial designed to evaluat...nd catheter procedure, the convergent procedure, f...fibrillation (AF). This prospective, feasibility ...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 1Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 3Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 4Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 5Patent Attorneys McDaniel and Stipkala to Confer at Summit November 4 2009 60349 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3
...ggest Clinically Meaningful Primary Endpoint for C...tional World Muscle Society,Congress -, SOUTH PLA...TC) today announced promising findings in patients... at the 13th International World Muscle Society,(W...assessing the utility,of the 6-minute walk test (6...
...ent inhibitor to be tested in AMD patients, LOUIS...privately held biotechnology company developing me...egeneration (AMD) announced today that the,Company...positive safety,results in its Phase I study. POT-...complement activation cascade that could otherwise...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2
...c has been a key participant in the area of blood ...us Medtronic autotransfusion systems allowed clini...latelets, as well as to determine requirements for...ch plasma (PRP) for a small amount of autologous b...
RX HERCULINK® PLUS Biliary Stent System
Response Catheter
Fast-Cath™ Guiding Introducers
Medicine Products: